CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2007-03-21 | GREENFIELD MICHAEL D Director | Grant or award | +100,000 | 300,000 | ||
| 2007-03-21 | SHORR ROBERT G L Director | Grant or award | +100,000 | 300,000 | ||
| 2006-09-17 | ARBEL IRIT Director | Returned to the company · Stock Option (right to buy) | −100,000 | 0 | ||
| 2006-09-17 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2006-05-02 | STOLICK DAVID Chief Financial Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2006-05-02 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2006-05-02 | Drucker Yoram Chief Operating Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2006-05-02 | GREENFIELD MICHAEL D Director | Grant or award | +100,000 | 200,000 | ||
| 2006-05-02 | SHORR ROBERT G L Director | Grant or award | +100,000 | 200,000 | ||
| 2006-02-06 | STOLICK DAVID Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −400,000 | 0 | ||
| 2006-02-06 | STOLICK DAVID Chief Financial Officer | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2005-05-27 | GREENFIELD MICHAEL D Director | Grant or award | +100,000 | 100,000 | ||
| 2005-05-27 | ARBEL IRIT Director | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2005-05-27 | SHORR ROBERT G L Director | Grant or award | +100,000 | 100,000 | ||
| 2005-03-29 | STOLICK DAVID Chief Financial Officer | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2004-12-31 | Drucker Yoram Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +685,760 | 685,760 | ||
| 2004-12-31 | YAFFA BECK President and CEO | Grant or award · Stock Option (right to buy) | +1,828,692 | 1,828,692 | ||
| 2004-09-22 | FRANKENBERGER MIKE Former Director and Officer | Purchase | +15,000 | $0.01 | $150 | 155,000 |
| 2004-08-01 | FRANKENBERGER MIKE Former Director and Officer | Purchase | +20,000 | $0.01 | $200 | 140,000 |
| 2004-05-21 | FRANKENBERGER MIKE Director | Returned to the company | −6,880,000 | $0.02 | $160K | 120,000 |
Page 21 of 22 · 426 trades